RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutics to Crown Laboratories

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutics to Crown Laboratories
REVANCE THERAP (NASDAQ: RVNC) Delayed: 3.65 --0 (-0%)
Previous Close $3.65    52 Week High $41.12 
Open $3.65    52 Week Low $12.35 
Day High $3.65    P/E N/A 
Day Low $3.65    EPS $-27.14 
Volume 9,900